Go backIncome
Assets
Total liabilities
Employees
AVALO THERAPEUTICS EUROPE
AVALO THERAPEUTICS EUROPE
is not in process of liquidation on Jun 15, 2024
To view all financial indicators, unlock this company.
Income
Financial indicator20202019
Cost of sales
-
-
Other operating expenses
░░░░░░░░
0%
░░░░░░░░
Operating profit
░░░░░░░░
0%
░░░░░░░░
Financial expenses
░░░░░░░░
0%
░░░░░░░░
Recurring financial expenses
░░░░░░░░
0%
░░░░░░░░
Profit before tax
░░░░░░░░
0%
░░░░░░░░
Net profit
-6.84K EUR
0%
-6.85K EUR
Profit (Loss) to be allocated
░░░░░░░░
0%
░░░░░░░░
Profit (Loss) for the year to be allocated
░░░░░░░░
0%
░░░░░░░░
Profit (Loss) brought forward from the previous year
░░░░░░░░
0%
░░░░░░░░
Assets
Financial indicator20202019
Total assets
21.4K EUR
7%
19.8K EUR
Current assets
░░░░░░░░
0%
░░░░░░░░
Total liabilities
Financial indicator20202019
Total liabilities
░░░░░░░░
0%
░░░░░░░░
Equity
░░░░░░░░
0%
░░░░░░░░
Debts
░░░░░░░░
0%
░░░░░░░░
Your trusted source for business data
Socials
English, USA
English, USA